Search research articles
Contact Us
Filters
Showing results (331-340 of 355) with videos related to
Page
of 36
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2012
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
Nathalie A Johnson, Graham W Slack, Kerry J Savage, et al.
Blood Advances
|
August 10, 2022
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma
Findlay Bewicke-Copley, Koorosh Korfi, Shamzah Araf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2019
Prognostic Significance of <i>MYC</i> Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium
Andreas Rosenwald, Susanne Bens, Ranjana Advani, et al.
BMC Infectious Diseases
|
June 10, 2021
Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers
Belinda M Jackson-Thompson, Emilie Goguet, Eric D Laing, et al.
Blood Advances
|
July 11, 2022
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV
G Tjitske Los-de Vries, Wendy B C Stevens, Erik van Dijk, et al.
Blood
|
May 24, 2013
Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing
Ryan D Morin, Karen Mungall, Erin Pleasance, et al.
Cancer Cell
|
May 18, 2013
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation
Wendy Béguelin, Relja Popovic, Matt Teater, et al.
Science (New York, N.Y.)
|
January 19, 2023
<i>BTG1</i> mutation yields supercompetitive B cells primed for malignant transformation
Coraline Mlynarczyk, Matt Teater, Juhee Pae, et al.
Nature Immunology
|
June 1, 2026
Regulatory factor X 7 limits Myc activity during B cell activation and suppresses Myc-dependent lymphomagenesis
Berenice A Fischer, Hanif J Khameneh, Jessica Guerra, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 31, 2025
High-grade B-cell lymphoma, not otherwise specified: an LLMPP study
Brett Collinge, Laura K Hilton, Jasper Wong, et al.
Page
of 36
Search research articles
Search
Showing results (331-340 of 355) with videos related to
Sort By:
Page
of 36
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2012
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
Nathalie A Johnson, Graham W Slack, Kerry J Savage, et al.
Blood Advances
|
August 10, 2022
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma
Findlay Bewicke-Copley, Koorosh Korfi, Shamzah Araf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2019
Prognostic Significance of <i>MYC</i> Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium
Andreas Rosenwald, Susanne Bens, Ranjana Advani, et al.
BMC Infectious Diseases
|
June 10, 2021
Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers
Belinda M Jackson-Thompson, Emilie Goguet, Eric D Laing, et al.
Blood Advances
|
July 11, 2022
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV
G Tjitske Los-de Vries, Wendy B C Stevens, Erik van Dijk, et al.
Blood
|
May 24, 2013
Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing
Ryan D Morin, Karen Mungall, Erin Pleasance, et al.
Cancer Cell
|
May 18, 2013
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation
Wendy Béguelin, Relja Popovic, Matt Teater, et al.
Science (New York, N.Y.)
|
January 19, 2023
<i>BTG1</i> mutation yields supercompetitive B cells primed for malignant transformation
Coraline Mlynarczyk, Matt Teater, Juhee Pae, et al.
Nature Immunology
|
June 1, 2026
Regulatory factor X 7 limits Myc activity during B cell activation and suppresses Myc-dependent lymphomagenesis
Berenice A Fischer, Hanif J Khameneh, Jessica Guerra, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 31, 2025
High-grade B-cell lymphoma, not otherwise specified: an LLMPP study
Brett Collinge, Laura K Hilton, Jasper Wong, et al.
Page
of 36